About 250 Mg -5 Ml Fulvestranl Injection
Discover the glorious 250 mg - 5 ml Fulvestranl Injection, now available at an unbeatable price when you buy online. Renowned for its efficacy in treating hormone receptor-positive metastatic breast cancer, this sterile injectable solution comes ready to use in a single-use glass vial. With a prescription required, its terrific quality meets all pharmacopeial standards. Enjoy peace of mind knowing the solution is odorless, clear to yellowish, and latex-free. Do not mix with other drugs. Offer available in India through reputed distributors, exporters, suppliers, and traders.
Comprehensive Oncology Solution for Targeted Therapy
The 250 Mg -5 Ml Fulvestranl Injection is used for the management of hormone receptor-positive metastatic breast cancer. This prescription antineoplastic agent is intended exclusively for intramuscular use and is administered by healthcare professionals. It is mainly used by adult patients struggling with advanced breast cancer, as part of a comprehensive oncological treatment plan. This product exemplifies trusted pharmaceutical care tailored specifically for those needing specialized cancer therapy.
Secure Packaging and Global Availability
Each Fulvestranl Injection is securely packaged in a single-use glass vial, ensuring sterility and efficacy. The product is dispatched promptly for both domestic sale and export markets, with a focus on key regions in India and abroad. Take advantage of the competitive sale price while benefiting from reliable packaging and swift shipment processes. Fulvestranl Injection is readily available through established distributors, ensuring a seamless supply chain and maximum quality control.
FAQ's of 250 Mg -5 Ml Fulvestranl Injection:
Q: How should the 250 Mg -5 Ml Fulvestranl Injection be administered?
A: This injection should be administered intramuscularly by a qualified healthcare professional to ensure safety and proper dosage.
Q: What are the primary benefits of Fulvestranl Injection for patients?
A: It is specifically designed for treating hormone receptor-positive metastatic breast cancer, helping to control disease progression in suitable patients.
Q: When should Fulvestranl Injection not be used?
A: It must not be used if the patient has a known hypersensitivity to Fulvestrant or its excipients, as this can cause serious reactions.
Q: Where is the main market for this product?
A: The main domestic market is India, with export availability to several international regions through licensed distributors and suppliers.
Q: What storage conditions are recommended for this injection?
A: Store the product below 30C and protect it from light to maintain its effectiveness throughout its 24-month shelf life.
Q: How is the product packaged for sale and transport?
A: It comes in a secure single-use glass vial, ensuring safety, sterility, and easy single-dose administration during shipment and delivery.